Price T Rowe Associates Inc Astrazeneca PLC Transaction History
Price T Rowe Associates Inc
- $935 Billion
- Q3 2025
A detailed history of Price T Rowe Associates Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Price T Rowe Associates Inc holds 49,124,476 shares of AZN stock, worth $4.39 Billion. This represents 0.4% of its overall portfolio holdings.
Number of Shares
49,124,476
Previous 51,942,963
5.43%
Holding current value
$4.39 Billion
Previous $3.63 Billion
3.83%
% of portfolio
0.4%
Previous 0.41%
Shares
20 transactions
Others Institutions Holding AZN
# of Institutions
1,499Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa21.2MShares$1.89 Billion0.6% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...